Dr. Sulaiman Al Habib Medical Services Group Second Quarter 2025 Earnings: Beats Expectations
SULAIMAN ALHABIB 4013.SA | 254.80 | -0.78% |
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Second Quarter 2025 Results
Key Financial Results
- Revenue: ر.س3.38b (up 32% from 2Q 2024).
- Net income: ر.س591.0m (up 6.5% from 2Q 2024).
- Profit margin: 18% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses.
- EPS: ر.س1.69 (up from ر.س1.59 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Dr. Sulaiman Al Habib Medical Services Group Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) also surpassed analyst estimates by 4.6%.
Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Healthcare industry in Saudi Arabia.
The company's shares are up 3.1% from a week ago.
Risk Analysis
Sulaiman Al Habib Medical Services Group (of which 1 doesn't sit too well with us!) you should know about.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.